SBIR/STTR Research Award
DEVELOP NEW COMMERCIALLY VIABLE DEVICES, TOOLS, TECHNOLOGIES OR INTEGRATED SYSTEMS FOR DRUG DETECTION AND DEACTIVATION TO DETER OPIOID THEFT IN HOSPITALS.
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- B & W TEK INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- M5VMM6KRMUG3
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
The Contractorwill use modern technology to develop a fully integratedcommercially viable device for controlled pharmaceutical drug detectiondeactivationand disposal to ensure compliance with DEA regulations and deter opioid theft
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- PHASE II: NEXT GENERATION CONTROLLED SUBSTANCE WASTE DETECTION, DEACTIVATION, AND DISPOSAL SYSTEM
- Mobile Health Point-of-Care Diagnostics for Tuberculosis
- Low Light Level Camera For Raman Spectroscopy
- Nano-Passivation of GaSb/InAs Strained Layer Superlattices Infrared Detector
- Characterization Of Noise And Detectivity Of Nano-BiCMOS Photo-Detectors
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
13 SBIR/STTR records share this UEI (2006–2021). Reported award amounts total $4,793,510. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services